NeuroOne Medical Chief Business Officer David J. Wambeke acquires 33,333 common shares worth $66,999.33

• NeuroOne Medical Technologies Chief Business Officer David J. Wambeke bought 33,333 common shares at USD 2.01.
• Direct holdings rose to 199,999 common shares following the purchase.
• He also received options for 35,000 shares at a USD 1.77 exercise price.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001971798-26-000005), on September 08, 2026, and is solely responsible for the information contained therein.